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The pituitary primordium Rathke’s pouch arises from the invaginat-
ing oral ectoderm in the early embryonic period and develops into
the anterior and intermediate lobes. The anterior lobe is composed
of ﬁve different endocrine cell types, luteinising hormone (LH)- and
follicle-stimulating hormone (FSH)-producing cells (gonadotrophs),
thyroid-stimulating hormone (TSH)-producing cells (thyrotrophs),
growth hormone (GH)-producing cells (somatotrophs), prolactin
(PRL)-producing cells (mammotrophs) and adrenocorticotrophic hor-
mone (ACTH)-producing cells (corticotrophs). Melanotrophs which
produce melanocyte-stimulating hormone (a-MSH) are present In
the intermediate lobe. In the processes of pituitary organogenesis,
these endocrine cells are terminally differentiated under control of
numerous signalling factors and transcription factors whose expres-
sion and function are coordinated under spatial–temporal regula-
tion. To date, many transcription factors important for pituitary
organogenesis, such as HESX1⁄RPX, PTX1, TBX19, LHX3, LHX4,
GATA2, PROP1 (prophet of PIT1), PIT1 and SF1, have been discov-
ered and characterised (1), although their precise functions in pitui-
tary organogenesis are not yet fully understood.
In addition, non-endocrine cells have been found in the pituitary.
One of the non-endocrine cells identiﬁed so far comprises a type of
folliculo-stellate cell, which was ﬁrst distinguished by electron
microscopy (2) and named in light of its characteristic shape and
follicle formation capacity (3). Although it was deﬁned later by the
presence of S100 protein, its functions in the pituitary and embry-
onic origin remain obscure (4,5). It is notable that folliculo-stellate
cells lining the marginal cell layer facing the residual lumen of the
Rathke’s pouch have long been hypothesised as pituitary stem⁄pro-
genitor cells (6–9). Over the last decade, the marginal cell layer has
often been proposed to be a pituitary stem⁄progenitor cell niche
providing a cell remodelling system to compensate for pituitary cel-
lular plasticity (10,11). Recent studies have demonstrated that cells
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We reported recently that a pituitary-speciﬁc transcription factor PROP1 is present in
SOX2-positive cells and disappears at the early stage of the transition from progenitor cell to
committed cell during the embryonic development of the rat pituitary. In the present study, we
examined the localisation and identiﬁcation of SOX2-positive and PROP1⁄SOX2-positive cells in
the neonatal and postnatal rat pituitaries by immunohistochemistry. Quantitative analysis of
immunoreactive cells demonstrated that SOX2-positive pituitary stem⁄progenitor cells are not
only predominantly localised in the marginal cell layer, but also are scattered in the parenchyma
of the adult anterior lobe. In the marginal cell layer, the number of PROP1⁄SOX2-positive cells
signiﬁcantly decreased after postnatal day 15, indicating that a signiﬁcant quantitative transition
is triggered in the marginal cell layer during the ﬁrst postnatal growth wave of the anterior
pituitary. By contrast, other phenotypes of SOX2-positive stem⁄progenitor cells that express
S100b appeared in the postnatal anterior pituitary. These data suggested that quantitative and
qualitative transition occurs by acquisition of a novel mechanism in terminal differentiation in
the postnatal development of the anterior pituitary.
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From Molecular to Translational Neurobiologyexpressing the gene for the HMG-box transcription factor SOX2, a
marker of stem⁄progenitor cells, are present in the adult pituitary
and have an ability to generate all of the pituitary cell types
(12,13). Fauquier et al. (12) demonstrated that a small population
of progenitor cells, which are present in the adult pituitary gland
and express Sox2, have an ability to form pituispheres in culture
and differentiate into all of the pituitary hormone-producing cell
types. Chen et al. (13) observed that SOX2 positive cells are more
abundant in the pituitary of early-postnatal mice at the age of the
ﬁrst pituitary growth wave (1-week-old) than in adult animals.
Thus, SOX2 might have a key role in maintenance of stem⁄progeni-
tor cells and⁄or differentiation of pituitary cell lineage. More
recently, we presented immunohistochemical observations that a
pituitary-speciﬁc factor PROP1 consistently coexists with SOX2
throughout the embryonic development of the pituitary (14).
Prop1 encodes a paired-like homeodomain transcription factor,
and is a heritable responsive gene for the combined pituitary hor-
mone deﬁciency in the Ames dwarf mice (Prop1-deﬁcient dwarf
mice) (15) and human patients showing absence or low levels of
GH, PRL, TSH, LH and FSH (16–18), as well as ACTH (19). Longitudi-
nal studies in Prop1-deﬁcient dwarf mice from early embryogenesis
through adulthood have demonstrated that PROP1 plays roles in
morphogenesis, apoptosis and proliferation in the developing pitui-
tary (20), as well as in cell migration in the expanding anterior lobe
(21). We further observed that Prop1-expression is transient in
PIT1-positive cells but absent in endocrine cells during embryonic
development, suggesting that PROP1 exists in SOX2-positive
stem⁄progenitor cells and disappears at the early stage of the tran-
sition of progenitor cells to committed cells in the embryonic devel-
opment of the pituitary (14).
In the present study, we aimed to track quantitatively the cells
expressing Prop1 and Sox2 in the postnatal development of the rat
anterior pituitary by the immunohistochemical technique. Finally,
we demonstrated that PROP1 is absent in any endocrine cells but
consistently coexists with SOX2 in non-endocrine cells, most of
which are S100-positive. Analysis of PROP1, SOX2 and S100b-posi-
tive cells in the anterior pituitary of S100b-green ﬂuorescent pro-
tein (GFP) transgenic rat (22) demonstrated that signiﬁcant
quantitative and qualitative transition in Sox2-expressing stem⁄pro-
genitor cells lining the marginal cell layer occurred in the postnatal
development of the anterior pituitary.
Materials and methods
Animals
Intact male Wistar-Imamichi strain rats, kept in a controlled environment,
were used. S100b-GFP transgenic rat was generated by fusing the S100b-
promoter to the reporter gene GFP (22). The present study was approved by
the committee on animal experiments of the School of Agriculture, Meiji
University.
Generation of antibody
Guinea pig anti-rat PROP1 antiserum was generated as described previously
(14). Brieﬂy, the cDNA of rat Prop1 corresponding to the C-terminal region
(amino acid residues 126–223) (Fig. 1A) was cloned into pET32a vector
(Novagen, Darmstadt, Germany) to generate the TrxA-His-tag fused protein.
After the fusion protein was separated by 12.5% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie
Brilliant Blue, the protein band corresponded to fusion protein of the C-ter-
minal region of PROP1 was cut and applied on immunisation in guinea pig.
Veriﬁcation of the generated anti-PROP1 antibody was accomplished by
western blotting ﬁrst (Fig. 1B) and then by immunohistochemistry (methods
described below) and in situ hybridisation using mirror sections (8 lm thick-
ness) of male rat pituitary (P5) (Fig. 1C). Western blotting was performed
using cell lysate of Chinese hamster ovary cells transfected with expression
vector pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) fused with the full length
cDNA of rat Prop1. After proteins were separated on a 10% SDS-PAGE, elec-
tro-blotting to a polyvinylidene ﬂuoride membrane was carried out. The
membrane was immunoreacted with anti-PROP1 antibody (dilution 1 : 5000)
and then secondary antibody of horseradish peroxidase-conjugated donkey
immunoglobulin (Ig)G against guinea pig IgG (dilution 1 : 25 000; Jackson
1 223 125 66
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Fig. 1. Immunohistochemistry and in situ hybridisation (A). Recombinant rat C-terminal region (closed box; amino acid residues 126–223) was used to gener-
ate the antibody after puriﬁed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. HD indicates a homeodomain important for DNA binding (amino
acid residues 66–125). (B). Western blotting was performed using cell lysate of Chinese hamster ovary cells which overexpressed rat PROP1 cDNA (+) and
empty vector ()). (C). Immunohistochemistry with anti-PROP1 antibody (left) and in situ hybridisation of Prop1 mRNA (right) were performed using mirror sec-
tions of rat pituitary (P5). Merged image of immunohistochemistry and light microscopy is shown in a center panel. Cells retaining both protein and mRNA
signals of Prop1 are indicated by asterisks (*). Scale bar = 10 lm.
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ised by TMB stabilised substrate for horseradish peroxides (Promega, Madi-
son, WI, USA). In situ hybridisation was performed as described previously
(23). Brieﬂy, frozen sections were treated with protease K (1 lg⁄ml; 10 min
at room temperature), ﬁxed in paraformaldehyde (4% for 20 min at 4  C)
and washed in phosphate buffer (pH 7.0). Digoxigenin (DIG)-labelled RNA
probes of each of both strands for rat Prop-1 cDNA were synthesised using
DIG RNA labeling Mix (Roche Diagnostics GmbH, Mannheim, Germany) and
the AmpliScribe T3 High Yield Transcription Kit (Epicentre, Madison, WI,
USA). Hybridisation and colour visualisation were performed according to
the manufacturer’s manual. Signals of in situ hybridisation were present in
the cytosol of the cells whose nuclei were stained by immunohistochemistry
(Fig. 1C).
Immunohistochemistry
The embryonic and postnatal pituitaries of Wistar-Imamichi rats and the
pituitaries of adult S100b-GFP transgenic rats were ﬁxed with 4% parafor-
maldehyde in 50 mM phosphate-buffered saline (PBS), pH 7.5, overnight at
4  C, followed by substitution with 30% sucrose in PBS. Frozen sections of
10 lm thickness in sagittal direction for embryonic day (E)18.5, E19.5 and
postnatal day (P)0 pituitaries and in coronal direction for postnatal pituitar-
ies were reacted with primary antibodies at the appropriate dilution at room
temperature overnight. Primary antibodies used were guinea pig antiserum
against rat PROP1 [dilution 1 : 1000, raised in our laboratory, as described
previously (14)], rabbit IgG against cow S-100 (dilution 1 : 100, immunogens
are S100b and S100A1; Dako, Ely, UK) and goat IgG against human SOX2
(dilution 1 : 500; Neuromics, Edina, MN, USA). Rabbit antisera against pitui-
tary hormones were: anti-rat aGSU (dilution 1 : 2000), -rat GH (dilution
1 : 8000) and -rat PRL (dilution 1 : 1500), which were provided by the
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)
through the courtesy of Dr A. F. Parlow, and anti-human ACTH (dilution
1 : 1000) antibody, which was provided by Dr S. Tanaka at Shizuoka Univer-
sity (Shizuoka, Japan). After washing with PBS, incubation with secondary
antibodies was then carried out using ﬂuorescein isothiocyanate- or Cy3-
conjugated AfﬁniPure donkey anti-guinea pig, rabbit and goat IgG (Jackson
ImmunoResearch) or Alexa Fluor 488 conjugated goat anti-rabbit IgG
(Molecular Probes, Inc., Eugene, OR, USA). The sections were washed with
PBS and then enclosed in Vectashield Mounting Medium with 4¢,6-diamidi-
no-2-phenylindole (Vector, Burlingame, CA, USA). Immunoﬂuorescence was
observed under ﬂuorescence microscopy with a confocal laser scanning
microscope (CLSM, Carl Zeiss, Oberkochen, Germany) and BZ-8000 (Keyence,
Osaka, Japan).
Quantitative real-time polymerase chain reaction (PCR)
Total RNAs were extracted from the whole pituitaries at E16.5 (n = 14),
E18.5 (n = 11), E20.5 (n = 10), E21.5 (n = 8) and P0 (n = 9), and from the
anterior lobes at P5 (n = 4), P10 (n = 8), P15 (n = 8), P30 (n = 6) and P60
(n = 3) using ISOGEN (Nippon Gene, Tokyo, Japan). Reverse transcript was
synthesised with Prime Script Reverse Transcriptase (Takara Bio, Kyoto,
Japan) using 1 lg of total RNA after DNase 1 treatment and was subjected
to quantitative real-time PCR on an ABI Prism 7500 Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA). Reaction was performed in SYBR
Green-Real Time PCR Master Mix Plus (Toyobo, Osaka, Japan), including
0.6 lM of speciﬁc primer set for each gene. Nucleotide sequences of primers
used were: Prop1,5 ¢-TCCTGACATCTGGGTTCGAG-3¢ and 5¢-GGAGTAGT
GACCGCTCTTGC-3¢; S100b,5 ¢-ACGAGCTCTCTCACTTCCTGGA-3¢ and 5¢-AG
TCACACTCCCCATCCCC-3¢; TAAT box binding protein (Tbp),5 ¢-GATCAA
ACCCAGAATTGTTCTCC-3¢ and 5¢-ATGTGGTCTTCCTGAATCCC-3¢. Each sample
was measured in duplicate in two independent experiments and data were
calculated by the comparative Cs method (DDCs method) to estimate the
gene copy number relative to Tbp as an internal standard. The DNA
sequence of PCR product of each sample was clariﬁed by analysis to be
bona ﬁde.
Statistical analysis
Data from the real-time PCR were analysed using Student’s t-test.
Results
Prop1 is expressed in the postnatal anterior lobe
We previously reported that immunoreactive signal of PROP1 occu-
pies all of the cells in the primordial pituitary Rathke’s pouch at
E13.5, then localises in the cells migrating to the expanding ante-
rior lobe at E16.5 (14). In the present study, localisation of Prop1-
expressing cells was investigated in the rat pituitary from E18.5 to
the postnatal period. At E18.5, PROP1-signals were predominantly
localised in the marginal cell layer facing the anterior side of the
lumen but not in the intermediate side and were scattered in the
parenchyma of the anterior lobe (Fig. 2). One day after at E19.5, in
addition to lining the marginal cell layer, the stratiﬁed pattern of
PROP1-signals in the parenchyma of the anterior lobe was observed
and became more apparent at P0, followed by decreasing the num-
ber of PROP1-positive cells in the marginal cell layer at P5. In the
sexually mature pituitary at P60, PROP1-signals were rarely present
in the marginal cell layer, although a small number of signals were
still observed in the parenchyma of the anterior lobe. This distribu-
tion pattern of PROP1-positive cells was mostly maintained at P600
(Fig. 2).
PROP1-positive cells consistently express Sox2
We previously observed that PROP1-positive cells deﬁnitely express
Sox2 in the embryonic pituitaries (14). Double-immunostaining for
PROP1 and SOX2 was performed for the postnatal pituitaries of P0,
P5, P60 and P600 (Fig. 3). All of the PROP1-positive cells lining the
marginal cell layer and stratifying the parenchyma of the anterior
lobe at P0 and P5 were positive for SOX2 but not vice versa. At
P60 and P600, it is notable that SOX2-positive cells were the major
population in the marginal cell layer, where PROP1 signals had
almost disappeared, and were scattered in the parenchyma of the
anterior lobe where the number of PROP1-positive cells had gradu-
ally decreased.
Signiﬁcant transition in localisation pattern of
PROP1⁄SOX2-positive cells in the marginal cell layer
of the postnatal pituitary
As observed above, the localisation pattern of PROP1-positive cells
showed a signiﬁcant transition. Hence, we performed longitudinal
evaluation of the proportion of PROP1-, SOX2- and PROP1⁄SOX2-
positive cells present in the marginal cell layer and the parenchyma
of the anterior lobe from P5 to P600 (Table 1). PROP1-positive cells
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20.8% of the cells in the parenchyma at P5. The values markedly
decreased to 5.2% and 7.4%, respectively, at P60, followed by a
further decrease to 1.2% and 3.9%, respectively, at P600. Interest-
ingly, the SOX2-positive cells in the marginal cell layer showed a
high proportion of 78–90% until P60 and still accounted for 43.8%
at P600. On the other hand, the SOX2-positive cells in the paren-
chyma gradually decreased from 27.3% at P5 to 11.3% at P600.
The proportion of PROP1⁄SOX2-positive cells in SOX2-positive
cells was also determined in the marginal cell layer and the paren-
chyma (Table 1). Marked decrease in the marginal cell layer was
observed from 87.9% at P5 to 5.8% at P60, whereas a modest
decrease from 76.3% at P5 to 49.6% at P60 was observed in the
parenchyma.
Prop1 expressed in non-endocrine cells in the adult anterior
lobe
We applied double immunohistochemistry using anti-PROP1 and
anti-hormone antibodies for the adult rat pituitaries to conﬁrm the
previous observation that PROP1 is absent in endocrine cells during
the embryonic period (14). As shown in Fig. 4A, none of the endo-
crine cells coexisted with the PROP1 signal, which is the same as
the observations made in the embryonic pituitary, indicating that
PROP1-positive cells are non-endocrine cells. Because folliculo-stel-
late cell is known as a major non-endocrine cell type, immunohis-
tochemistry of S100 protein, which is one of the molecular markers
of folliculo-stellate cells, was investigated in the present study. The
results obtained demonstrated that Prop1 was certainly expressed
in S100-positive cells (Fig. 4B, arrow). In addition, we found that
some cells were positive only for S100 or PROP1 (Fig. 4B, open and
closed arrowheads, respectively). For additional conﬁrmation, the
immunohistochemistry of PROP1 was examined using the S100b-
GFP transgenic rat (22) because S100b-positive cells of the trans-
genic rat are easily distinguishable by the S100b-promoter-derived
expression of the reporter gene, GFP (Fig. 4C). Immunohistochemis-
try showed the same image as that of a normal rat using anti-
S100 antibody (Fig. 4B). Thus, positive cells only for S100b or
PROP1 (Fig. 4B, open and closed arrowheads, respectively) were also
present.
Classiﬁcation of non-endocrine cells in the adult anterior
lobe
Classiﬁcation of non-endocrine cells was examined by localisation
of PROP1, SOX2 and S100b using the adult pituitary of S100b-GFP
P5
E19.5 E18.5
P0
P60 P600
Fig. 2. Immunohistochemistry of PROP1. Frozen sections of the embryonic day (E) and postnatal day (P) pituitaries (E18.5, E19.5, P0, P5, P60 and P600) were
reacted with anti-PROP1 antiserum. PROP1 is visualised with Cy3 (red) and is overlaid with nuclear staining with 4¢,6-diamidino-2-phenylindole (blue). The dot-
ted line and arrowhead indicate the outline of the anterior pituitary and the marginal cell layer, respectively. Scale bar = 50 lm.
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in the 60-day-old rat pituitary (Fig. 5A): Type1; SOX2-positive,
Type2; SOX2⁄PROP1-positive, Type3; SOX2⁄PROP1⁄S100b-positive,
Type4; SOX2⁄S100b-positive, and Type5; S100b-positive.
The number of cells belonging to each cell type in the marginal
cell layer and the parenchyma of the anterior lobe of P60 was
counted for three and four areas, respectively, and the proportion
is shown in Fig. 5. In the marginal cell layer, Type2 (SOX2⁄PROP1-
positive) was only 1.4% and major cell types were Type1 (SOX2-
positive, 31.1%) and Type4 (SOX2⁄S100b-positive, 45.9%) (Fig. 5A).
On the other hand, in the parenchyma of the anterior lobe, Type3
(SOX2⁄PROP1⁄S100b-positive) was a major population, accounting
for 59.7%, whereas the proportions of other cell types ranged from
6.6 to 12.8% (Fig. 5B). It is noteworthy that cells positive only for
PROP1 were not present and all of the PROP1-positive cells
expressed Sox2, together or not with S100b, as far as was exam-
ined. Classiﬁcation of non-endocrine cells in the adult anterior lobe
demonstrated that the distribution pattern of the SOX2-positive
stem⁄progenitor cell population differs between the marginal cell
layer and the parenchyma of the anterior lobe. However, we could
not characterise a temporal transition in the distribution pattern
because S100b-positive cells were ﬁrst detected in the postnatal
pituitary at P5, when analysed by the immunohistochemical tech-
nique (data not shown). Next, we performed quantitative real-time
PCR to estimate the mRNA level of the S100b in the pituitary of
the prenatal to postnatal period.
Expression proﬁle of Prop1 and S100b in pituitary
development
After the late stage of embryonic development, the expression of
Prop1 was speciﬁc to the anterior lobe (Fig. 2) and it is known that
the expression level of S100b is higher in the posterior lobe than
that in the anterior lobe (22). For this reason, analysis of the ante-
rior lobe was essential, although it was practically difﬁcult to iso-
late the anterior lobe from the embryonic pituitary. Therefore,
quantitative real-time PCR was performed using total RNAs pre-
pared from the whole pituitaries of prenatal and neonatal periods
(Fig. 6A) and from the anterior lobes of the postnatal period
(Fig. 6B). The results obtained revealed that Prop1 was expressed
from the prenatal through the postnatal period and its level was
gradually decreased. On the other hand, S100b started to be
expressed at around E21.5 and its expression level increased linearly
after P15 in the anterior lobe. Because the expression level of
S100b was ﬁve-fold higher in the posterior-intermediate lobe than
in the anterior lobe at P5 (data not shown), the expression level in
the anterior lobe at E21.5 and P0 might be low, resulting in a low
S100b protein level and failure of detection by the immunoreaction.
P0
P5
P60
P600
(A)( B)( C)( D)( E)
Fig. 3. Immunohistochemistry of PROP1 and SOX2. Immunohistochemistry of PROP1 (A) and SOX2 (B) was performed using the rat pituitaries of postnatal
day (P)0, P5, P60 and P600. PROP1 (red)- and SOX2 (green)-signals are merged with 4¢,6-diamidino-2-phenylindole staining (blue, C) and the boxed area is
enlarged (D: PROP1, E: SOX2). (Scale bar = 50 lm). Arrow and arrowhead indicate PROP1⁄SOX2-positive cell and SOX2-positive cell, respectively.
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ﬁrst appear at around P0.
Discussion
In the present study, we aimed to conduct a quantitative and quali-
tative analysis of pituitary stem⁄progenitor cells in the postnatal
pituitary development by tracking down the cells expressing a
stem⁄progenitor marker Sox2 and a pituitary-speciﬁc transcription
factor Prop1 using immunochemical techniques. Consequently, we
demonstrated that a signiﬁcant transition in the proportion of
PROP1⁄SOX2-positive cells occurred in the marginal cell layer of
the rat postnatal pituitary from the neonatal to the adult period,
whereas only a gradual quantitative change in the parenchyma of
the anterior lobe was observed. Thus, we suggested that a qualita-
tive transition is triggered in the marginal cell layer within the sec-
ond postnatal week.
Our previous study (14) revealed that the expression of Sox2 was
observed in all of the cells in the invaginating oral ectoderm at
E11.5 up to the pituitary primordial Rathke’s pouch at E13.5. After
E14.5, SOX2-positive cells consistently accounted for almost all of
the cells in the marginal cell layer facing both the anterior and
intermediate sides of the residual lumen and were also scattered in
the expanding parenchyma of the anterior and intermediate lobes.
At E16.5, approximately 45% of the cells in the parenchyma of the
anterior lobe were SOX2-positive. In the present study, Sox2 was
persistently expressed in the marginal cell layer of both sides during
the postnatal period, and 90% of the cells of the marginal cell layer
facing the anterior lobe were SOX2-positive even at P60. In the
parenchyma of the anterior lobe, the proportion of SOX2-positive
cells decreased to 27% at P5 with the progress of pituitary organo-
genesis and further decreased to 17.5% at P15. During this 2-week
postnatal period, the ﬁrst postnatal growth wave of the rat anterior
pituitary occurs as shown by the peak in the number of proliferat-
ing cells (24) and observations in the mouse pituitary (13,24,25).
Although we did not count the total number of cells, a decrease in
the proportion of SOX2-positive cells might be the result of an
increased number of cells in the parenchyma of the anterior lobe.
On the other hand, the expression of Prop1 started at E11.5 and
eventually accounted for almost all of the cells composing the
Rathke’s pouch at E13.5. When pituitary organogenesis started to
progress, unlike SOX2, PROP1-positive cells existed mainly in the
marginal cell layer of the anterior side and in the parenchyma of
the expanding anterior lobe; those in the intermediate lobe disap-
peared completely by the neonatal period (14). After birth, the pro-
portion of PROP1-positive cells on the anterior side of the marginal
cell layer decreased gradually from 69% at P5 to 27% at P15, and
thereafter rapidly decreased to 5% until P60, whereas the propor-
tion of SOX2-positive cells was maintained at 90% during the same
period. Instead of the signiﬁcant difference between SOX2 and
Table 1. Temporal and Spatial Alteration in the Proportion of PROP1- and SOX2-Positive Cells.
Marginal cell layer
Postnatal day n*
Cell number Cell population (%)
DAPI PROP1 SOX2 PROP1⁄DAPI SOX2⁄DAPI PROP1 + SOX2⁄SOX2
5 4 264 181 206 68.6  9.1 78.0  9.1 87.9  3.0
9 4 332 170 NC 51.2  6.6 NC NC
15 4 286 77 237 26.9  7.1 82.9  2.9 32.5  9.4
60 3 115 6 103 5.2  2.5 89.6  1.8 5.8  2.7
120 6 535 38 286 7.1  2.6 53.5  6.1 13.3  6.2
600 6 489 6 214 1.2  1.2 43.8  10.1 2.8  2.6
Parenchyma
Postnatal day n*
Cell number Cell population (%)
DAPI PROP1 SOX2 PROP1⁄DAPI SOX2⁄DAPI PROP1 + SOX2⁄SOX2
5 23 2007 418 548 20.8  5.3 27.3  6.3 76.3  10.0
9 22 1832 307 NC 16.8  2.2 NC NC
15 20 3058 338 536 11.1  3.3 17.5  3.8 63.1  14.6
60 48 3541 262 528 7.4  4.0 14.9  7.3 49.6  25.4
120 44 4391 191 480 4.3  2.6 10.9  3.8 39.8  22.9
600 25 4855 187 549 3.9  2.5 11.3  4.4 34.1  23.9
Cell number of positives was counted for the marginal cell layer and parenchyma of the rat pituitary postnatal day (P)5, P9, P15, P60, P120 and P600. Cell
number of PROP1-SOX2 positives was also counted for both areas, and the population of each cell type was calculated. *n: number of areas (measuring 0.09–
0.2 mm
2) in which 4¢,6-diamidino-2-phenylindole (DAPI)-nuclei-stained, PROP1- and SOX2-positives were counted. NC, Not counted.
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lobe, the proportion of both SOX2- and PROP1-positive cells
decreased gradually from 27.3% at P5 to 11.3% at P600 and from
20.8% at P5 to 3.9% at P600, respectively. Characteristically, the
PROP1-positive cells consistently expressed SOX2 but not vice versa
as far as examined from E11.5 to P600. These data obtained by
double-immunohistochemical analysis using anti-PROP1 and anti-
SOX2 antibodies conﬁrmed two ﬁndings. First, pituitary stem⁄pro-
genitor cells not only exist mostly in the marginal cell layer, but
also in the parenchyma of the anterior lobe. Second, a qualitative
transition might be triggered in the marginal cell layer on the ante-
rior side during the ﬁrst postnatal growth wave of the anterior
pituitary, whereas only a gradual quantitative change is observed in
the parenchyma of the anterior lobe (Fig. 7).
The marginal cell layer has been proposed to contain a pituitary
stem⁄progenitor cell niche in the postnatal pituitary (10–13,26–30).
A tissue stem⁄progenitor cell is deﬁned by its potency to generate
differentiated progenies and its long-term self-renewal capacity. It
was shown that Sox2-expressing cells are multipotent stem⁄
progenitor cells to generate all of the major cell types in the adult
mouse pituitary (12). Analysis of the side population, which is
rich in cells with stem⁄progenitor-like features, revealed that non-
Sca1
high fraction in the side population of the adult mouse pituitary
clusters Sox2-expressing cells and possesses an ability to form pit-
uispheres to be differentiated into all of the pituitary endocrine cell
types (13). These Sox2-expressing stem⁄progenitor cells are local-
ised in the marginal cell layer but are also scattered in the paren-
chyma of the anterior pituitary (12,13). Chen et al.(13) also
reported that SOX2-positive cells are more abundant in the period
of the ﬁrst pituitary growth wave (P7) than in the adult mouse
pituitary. These data correspond to our results showing that pitui-
tary Sox2-expressing stem⁄progenitor cells are predominantly
localised in the marginal cell layer but are scattered in the paren-
chyma of the anterior lobe, and also that the number of Sox2-
expressing cells gradually decreases in the adult anterior lobe. From
another point of view in the long-term self-renewal capacity of
PRL GH ACTH α
PROP1 S100β-GFP Merge
PROP1 S100 Merge
(B)
(A)
(C)
Fig. 4. Double-immunohistochemical staining of PROP1 in endocrine- and non-endocrine cells of the adult rat pituitary. Localisation of PROP1 in endocrine
cells (A) and non-endocrine cells (B) was examined using the pituitaries of postnatal day (P)60. PROP1 is visualised with Cy3 (red) and pituitary hormones [pro-
lactin (PRL), growth hormone (GH), adrenocorticotrophic hormone (ACTH) and a subunit] and S100 proteins are visualised with ﬂuorescein isothiocyanate
(green). Visualisation of S100b was also performed using S100b-green ﬂuorescent protein (GFP) transgenic rat of P60 (C). PROP1 signals localise in S100b-
positive non-endocrine cells but not in any endocrine cells. Scale bar = 20 lm. An arrow indicates the PROP1⁄S100b-positive cell. Open and closed arrow-
heads indicate the cell positive only for S100 or PROP1, respectively.
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visualises the length of telomeres, revealed that cells carrying the
longest telomere localise not only mostly in the marginal cell layer,
but also in the parenchyma of the anterior lobe. This again indi-
cates the existence of pituitary stem⁄progenitor cells not only in
the marginal cell layer, but also in the parenchyma of the anterior
lobe (27). These data correspond to the localisation pattern of
Sox2-expressing cells described in the present study.
In the present study, we further indicated that PROP1-positive
cells consistently express Sox2 from the prenatal to the postnatal
period. By RT-PCR analysis of a side population obtained from the
mouse adult pituitary, Chen et al.(13) demonstrated that Prop1 is
expressed in the cells belonging to the non-Sca1
high fraction that
clusters pituitary progenitor cells. Garcia-Lavandeira et al. (27)found
a pituitary stem⁄progenitor cell niche characterised by the expres-
sion of Gfra2 (a Ret co-receptor for Neurturin), Prop1 and stem cell
markers such as Sox2 in the marginal cell layer. However, their
immunohistochemical analysis showed that PROP1-positive cells are
present only in the marginal cell layer but not in the parenchyma
of the rat anterior lobe. Garcia-Lavandeira et al. (27) indicated that
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Area SOX2 SOX2/PROP1 SOX2/PROP1/S100β SOX2/S100β S100β Total
a 6 20 68 11 11 116
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Fig. 5. Classiﬁcation of non-endocrine cells with regard to the expression of Prop1, Sox2 and S100b. Immunohistochemistry of adult 60-day-old S100b-green
ﬂuorescent protein (GFP) transgenic rat was examined with double immunohistochemical staining of PROP1 (red) and SOX2 (blue) under S100b-promoter-
derived expression of GFP (green). Merged image is shown in the right panel. Scale bar = 20 lm. Expression pattern of Prop1, Sox2 and S100b was classiﬁed
into ﬁve cell types (type 1 to type 5). The number of cells belonging to each cell type was counted in randomly selected one area (a, b and c) in each of three
sections of two pituitaries for the marginal cell layer (A) and one area (a–d) in each of four sections of two pituitaries for the parenchyma of the anterior lobe
(B). The proportion of each cell type was shown as a bar graph.
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in the cytosol⁄nuclei, in contrast to our data indicating PROP1 sig-
nals are observed in the nuclei. In addition, in situ hybridisation
demonstrated the presence of a Prop1 signal in the parenchyma of
the mouse anterior lobe (15), supporting our data obtained by
immunohistochemistry. These discrepancies might be caused by the
difference in the properties of anti-PROP1 antibody used. Indeed,
the antigens used are somewhat different between the C-terminal
region 126–223 of rat PROP1 (present study) and the C-terminal
region 151–223 of mouse PROP1 (Garcia-Lavandeira et al.). Identity
in the C-terminal region 151–223 between mouse and rat is 84%,
suggesting a possible difference in antigenicity, as well as in
sensitivity.
Recently, Gleiberman et al.(26) hypothesised that the adult ante-
rior pituitary is composed of two different terminally-differentiated
endocrine cells originating from embryonic precursors and adult
stem cells by the cell-lineage labelling technique using Nestin-Cre
transgenic mouse. This hypothesis makes it possible to propose that
both embryonic precursors and adult stem cells are mixed together
in the marginal cell layer and the parenchyma of the anterior lobe
from embryonic to postnatal development. Our observation that sig-
niﬁcant quantitative and qualitative transition in the marginal cell
layer occurs during the ﬁrst postnatal growth wave of the anterior
pituitary suggests that a hierarchical change from embryonic pre-
cursors to adult stem cells may be triggered in the marginal cell
layer during this stage but not in the parenchyma of the anterior
lobe. However, Galichet et al. (31) presented a dissimilar result using
similar Nestin-Cre transgenic mouse. The discrepancy may have
arisen from the difference in the gene construct used. Nevertheless,
we cannot exclude another possible explanation proposing that
there is only one pool of Sox2-expressing stem⁄progenitor cells
with a transitioning expression of Prop1 and S100b in the pituitary
development. Further investigations are required to clarify this.
In our previous study (14) we proposed that PROP1 exists in
Sox2-expressing stem⁄progenitor cells and disappears at the ﬁrst
stage of the transition of progenitor cells to committed cells and
does not exist in any endocrine cells during embryonic develop-
ment. In the present study, we demonstrate that PROP1 mostly
exists in S100-positive folliculo-stellate cells but not in any endo-
crine cells during postnatal development. Although the majority of
non-endocrine cells are folliculo-stellate cells, the existence of
unidentiﬁed cell types in the adult anterior lobe is evident from the
accumulating data, such as that obtained from nestin-immunoreac-
tive cells (32). Folliculo-stellate cells themselves remain to be char-
acterised clearly because they show heterogeneity in function, and
their origin is unclear (4,5).
In recent years, a number of experimental studies have suggested
that folliculo-stellate cells are candidates for pituitary stem⁄pro-
genitor cells (10,11,33,34). Furthermore, some SOX2-positive
stem⁄progenitor cells express S100 (12,27) and analysis of pitui-
spheres revealed that S100-positive cells appear transiently on the
way to generating terminally-differentiated endocrine cells (12). In
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Fig. 6. Expression proﬁle of Prop1 and S100b during pituitary development.
Quantitative real-time polymerase chain reaction (PCR) was performed to
estimate mRNA level of Prop1 and S100b using total RNAs extracted from
the whole pituitaries at embryonic day (E)16.5 to postnatal day (P)0 (A) and
from the anterior lobes at P5 to P60 (B). Each sample was measured in
duplicate in two independent experiments, and data were calculated by
comparative CT method to estimate the relative copy number to TAAT box
binding protein (Tbp) as an internal standard. The data are presented as the
mean  SD of duplicate PCR in two independent experiments. Open and
closed bars indicate Prop1 and S100b, respectively. Signiﬁcance was exam-
ined by comparison with the value of E21.5 (A)o rP 5( B). *P < 0.01 and
**P < 0.05.
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Fig. 7. Transition from PROP1 to S100 in stem⁄progenitor cells during pituitary development. Pituitary stem⁄progenitor cells express Sox2 in the early primor-
dium and then start to co-express Prop1. During embryonic development of the pituitary, stem⁄progenitor cells line the marginal cell layer (MCL) and migrate
in the parenchyma. After birth, transition of PROP1 to S100 progresses in the stem⁄progenitor cells at MCL and Sox2⁄Prop1⁄S100-expressing cells migrate in
the parenchyma of the anterior pituitary where Sox2⁄Prop1-expressing embryonic stem⁄progenitor cells still locate.
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PROP1, SOX2 and S100b using adult S100b-GFP transgenic rats in
which folliculo-stellate cells are visualised by GFP expressed under
the control of S100b-promoter (22). We could classify non-endo-
crine cells into ﬁve groups by the expression pattern of PROP1,
SOX2 and S100b: Type1, SOX2-positive; Type2, SOX2⁄PROP1-posi-
tive; Type3, SOX2⁄PROP1⁄S100b-positive; Type4, SOX2⁄S100b-posi-
tive; and Type5, S100b-positive. The proportion of each cell type
was different in the marginal cell layer and the parenchyma of the
anterior lobe. Eighty percent of the non-endocrine cells in the mar-
ginal cell layer were Type1 (SOX2-positive, 31%) and Type4
(SOX2⁄S100b-positive, 46%). On the other hand, the majority of
them in the parenchyma of the anterior lobe were Type3 (SOX2⁄-
PROP1⁄S100b-positive, 60%). Because the expression of S100b
started at around P0, SOX2⁄S100b-positive cells would hypotheti-
cally be adult stem⁄progenitor cells. This might mean that
SOX2-expressing adult stem⁄progenitor cells generate SOX2⁄S100b-
positive cells, followed by expressing Prop1 in the marginal cell layer
of the adult pituitary. Then, most of these SOX2⁄S100b⁄PROP1-
positive cells might migrate into the parenchyma of the anterior
lobe and might compose major precursor-endocrine cells in the
parenchyma, awaiting the next stimuli to be differentiated. On the
other hand, in the parenchyma of the adult anterior lobe, Sox2-
expressing embryonic stem⁄progenitor cells are still present to gen-
erate SOX2⁄PROP1-positive cells as precursor-endocrine cells. Thus,
endocrine cells in the adult anterior lobe are composed of stem⁄pro-
genitor cells with a different origin (Fig. 7). From another point of
view, PROP1 exists transiently in PIT1-positive commitment cells,
although the rate of coexistence declines gradually and reaches
almost 0% at E21.5 (14). This coexistence of PROP1 and PIT1 com-
pletely disappears in the postnatal anterior lobe (data not shown),
suggesting that PROP1 plays different roles or a different develop-
mental system emerges and becomes dominant in the postnatal
development. We have postulated the latter possibility, although the
transition in the roles of PROP1 remain to be studied. Most recently,
it was reported that prop1 knockdown in zebraﬁsh caused abnormal
morphology and gene expression in the early pituitary development,
although gradual reverse was observed during late development,
suggesting the existence of other ﬁsh-speciﬁc pathways down-
stream of prop1 (35). Although zebraﬁsh is quite a different species
from mammals, this result is suggestive for understanding the func-
tion of the PROP1 in embryonic and postnatal periods.
In summary, we have demonstrated that pituitary stem⁄progeni-
tor cells are not only mostly present in the marginal cell layer, but
also are scattered in the parenchyma of the anterior lobe. More-
over, a signiﬁcant quantitative and qualitative transition occurred
in the marginal cell layer during the ﬁrst postnatal growth wave in
the anterior pituitary. We propose that this transition might be a
hierarchical change in pituitary stem⁄progenitor cells from those of
embryonic to adult stages.
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